SEATTLE, WA, DexCare, a leading patient demand and care access platform, announced the close of its $75 million Series C funding round led by ICONIQ Growth.
DexCare, a leading patient demand and care access platform, announced the close of its $75 million Series C funding round led by ICONIQ Growth.
The funding round included participation from existing partners Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
